Cargando…
First Description of Reduced Pyruvate Dehydrogenase Enzyme Activity Following Subarachnoid Hemorrhage (SAH)
Object: Several previous studies reported metabolic derangements and an accumulation of metabolic products in the early phase of experimental subarachnoid hemorrhage (SAH), which may contribute to secondary brain damage. This may be a result of deranged oxygen utilization due to enzymatic dysfunctio...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306203/ https://www.ncbi.nlm.nih.gov/pubmed/28261039 http://dx.doi.org/10.3389/fnins.2017.00037 |
_version_ | 1782507151084748800 |
---|---|
author | Lilla, Nadine Füllgraf, Hannah Stetter, Christian Köhler, Stefan Ernestus, Ralf-Ingo Westermaier, Thomas |
author_facet | Lilla, Nadine Füllgraf, Hannah Stetter, Christian Köhler, Stefan Ernestus, Ralf-Ingo Westermaier, Thomas |
author_sort | Lilla, Nadine |
collection | PubMed |
description | Object: Several previous studies reported metabolic derangements and an accumulation of metabolic products in the early phase of experimental subarachnoid hemorrhage (SAH), which may contribute to secondary brain damage. This may be a result of deranged oxygen utilization due to enzymatic dysfunction in aerobic glucose metabolism. This study was performed to investigate, if pyruvate dehydrogenase enzyme (PDH) is affected in its activity giving further hints for a derangement of oxidative metabolism. Methods: Eighteen male Sprague-Dawley rats were randomly assigned to one of two experimental groups (n = 9): (1) SAH induced by the endovascular filament model and (2) sham-operated controls. Mean arterial blood pressure (MABP), intracranial pressure (ICP), and local cerebral blood flow (LCBF; laser-Doppler flowmetry) were continuously monitored from 30 min before until 3 h after SAH. Thereafter, the animals were sacrificed and PDH activity was measured by ELISA. Results: PDH activity was significantly reduced in animals subjected to SAH compared to controls. Conclusion: The results of this study demonstrate for the first time a reduction of PDH activity following SAH, independent of supply of substrates and may be an independent factor contributing to a derangement of oxidative metabolism, failure of oxygen utilization, and secondary brain damage. |
format | Online Article Text |
id | pubmed-5306203 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-53062032017-03-03 First Description of Reduced Pyruvate Dehydrogenase Enzyme Activity Following Subarachnoid Hemorrhage (SAH) Lilla, Nadine Füllgraf, Hannah Stetter, Christian Köhler, Stefan Ernestus, Ralf-Ingo Westermaier, Thomas Front Neurosci Neuroscience Object: Several previous studies reported metabolic derangements and an accumulation of metabolic products in the early phase of experimental subarachnoid hemorrhage (SAH), which may contribute to secondary brain damage. This may be a result of deranged oxygen utilization due to enzymatic dysfunction in aerobic glucose metabolism. This study was performed to investigate, if pyruvate dehydrogenase enzyme (PDH) is affected in its activity giving further hints for a derangement of oxidative metabolism. Methods: Eighteen male Sprague-Dawley rats were randomly assigned to one of two experimental groups (n = 9): (1) SAH induced by the endovascular filament model and (2) sham-operated controls. Mean arterial blood pressure (MABP), intracranial pressure (ICP), and local cerebral blood flow (LCBF; laser-Doppler flowmetry) were continuously monitored from 30 min before until 3 h after SAH. Thereafter, the animals were sacrificed and PDH activity was measured by ELISA. Results: PDH activity was significantly reduced in animals subjected to SAH compared to controls. Conclusion: The results of this study demonstrate for the first time a reduction of PDH activity following SAH, independent of supply of substrates and may be an independent factor contributing to a derangement of oxidative metabolism, failure of oxygen utilization, and secondary brain damage. Frontiers Media S.A. 2017-02-14 /pmc/articles/PMC5306203/ /pubmed/28261039 http://dx.doi.org/10.3389/fnins.2017.00037 Text en Copyright © 2017 Lilla, Füllgraf, Stetter, Köhler, Ernestus and Westermaier. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Lilla, Nadine Füllgraf, Hannah Stetter, Christian Köhler, Stefan Ernestus, Ralf-Ingo Westermaier, Thomas First Description of Reduced Pyruvate Dehydrogenase Enzyme Activity Following Subarachnoid Hemorrhage (SAH) |
title | First Description of Reduced Pyruvate Dehydrogenase Enzyme Activity Following Subarachnoid Hemorrhage (SAH) |
title_full | First Description of Reduced Pyruvate Dehydrogenase Enzyme Activity Following Subarachnoid Hemorrhage (SAH) |
title_fullStr | First Description of Reduced Pyruvate Dehydrogenase Enzyme Activity Following Subarachnoid Hemorrhage (SAH) |
title_full_unstemmed | First Description of Reduced Pyruvate Dehydrogenase Enzyme Activity Following Subarachnoid Hemorrhage (SAH) |
title_short | First Description of Reduced Pyruvate Dehydrogenase Enzyme Activity Following Subarachnoid Hemorrhage (SAH) |
title_sort | first description of reduced pyruvate dehydrogenase enzyme activity following subarachnoid hemorrhage (sah) |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306203/ https://www.ncbi.nlm.nih.gov/pubmed/28261039 http://dx.doi.org/10.3389/fnins.2017.00037 |
work_keys_str_mv | AT lillanadine firstdescriptionofreducedpyruvatedehydrogenaseenzymeactivityfollowingsubarachnoidhemorrhagesah AT fullgrafhannah firstdescriptionofreducedpyruvatedehydrogenaseenzymeactivityfollowingsubarachnoidhemorrhagesah AT stetterchristian firstdescriptionofreducedpyruvatedehydrogenaseenzymeactivityfollowingsubarachnoidhemorrhagesah AT kohlerstefan firstdescriptionofreducedpyruvatedehydrogenaseenzymeactivityfollowingsubarachnoidhemorrhagesah AT ernestusralfingo firstdescriptionofreducedpyruvatedehydrogenaseenzymeactivityfollowingsubarachnoidhemorrhagesah AT westermaierthomas firstdescriptionofreducedpyruvatedehydrogenaseenzymeactivityfollowingsubarachnoidhemorrhagesah |